IGC Pharma, Inc. (NYSE: IGC)

$0.35 +0.03 (+9.76%)
As of Apr 22, 2026 03:59 PM
Sector: Healthcare Industry: Biotechnology CIK: 0001326205
Market Cap 27.64 Mn
P/E -4.55
P/S 24.99
Div. Yield 0.00
Total Debt (Qtr) 132,000.00
Revenue Growth (1y) (Qtr) -53.64
Add ratio to table...

About

Product and Service Breakdown of Revenue (2025)

Peer comparison

Companies in the Biotechnology
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 VRTX Vertex Pharmaceuticals Inc / Ma 111.64 Bn 28.22 9.30 -
2 REGN Regeneron Pharmaceuticals, Inc. 78.17 Bn 17.32 5.45 1.99 Bn
3 ALNY Alnylam Pharmaceuticals, Inc. 40.41 Bn 146.87 12.83 -
4 RVMD Revolution Medicines, Inc. 28.31 Bn -25.07 34,108.71 -
5 ZLAB Zai Lab Ltd 26.77 Bn -152.75 110.41 0.20 Bn
6 MESO Mesoblast Ltd 24.41 Bn -191.25 1,419.53 0.12 Bn
7 RPRX Royalty Pharma plc 21.27 Bn 27.64 8.94 8.95 Bn
8 MRNA Moderna, Inc. 21.10 Bn -7.46 10.85 0.59 Bn